More Australian Clinical Labs Ltd news
Australian Clinical Labs LtdASX: ACL

Fourth Supplementary Bidder's Statement

Nov 9, 2023 at 7:21 AM EST · Issued by Australian Clinical Labs Ltd

Filed with ASX · Nov 9, 2023 at 7:21 AM EST

On 6ix: 6ix.com/news/fourth-supplementary-bidders-statement-3

Australian Clinical Labs Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Australian Clinical Labs Ltd on 6ix

Story so far

  • Third Supplementary Bidder's StatementOct 9, 2023
  • Second Supplementary Bidder's StatementMay 22, 2023
  • First Supplementary Bidder's StatementApr 14, 2023

Earlier from Australian Clinical Labs

  • Extension of offer period - notice of variationOct 31, 2023
  • Takeover offer for Healius - extension of offer periodOct 31, 2023
  • Notice of fulfilment of conditionsOct 8, 2023
  • Third Supplementary Bidder's StatementOct 8, 2023
  • HLS: Supplementary Target's StatementSep 4, 2023

Later from Australian Clinical Labs

  • Takeover offer - Healius entitlement offerNov 20, 2023
  • AXX: Accc opposes Australian Clinical Labs' proposed acquisDec 14, 2023
  • Intention to withdraw takeover offer for HealiusDec 14, 2023
  • HLS: ACCC Rejection&ACL Notice of Intention to Withdraw OfferDec 15, 2023
  • Notice of withdrawal of offer - Healius LimitedDec 21, 2023
All Australian Clinical Labs news releases↗

Follow Australian Clinical Labs into a list and get an email when it puts out news.

Follow Australian Clinical Labs
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer